Useful resources |
Infliximab for the treatment of rheumatoid arthritis (Cochrane Review) ABSTRACT Background: Infliximab is a human murine chimeric anti-tumour necrosis factor alpha monoclonal antibody recently approved for the treatment of refractory RA. |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |